PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
24-Nov-2022 Original-Research: HAEMATO AG (von First Berlin Equity Research GmbH) HAEMATO AG
24-Nov-2022 Amarin Goes for Growth with New UK and Ireland General Manager Amarin
24-Nov-2022 BC Platforms Partners with EU Funded, AI-Driven, Cancer Data Initiative BC Platforms
24-Nov-2022 Research & Development roles driving jobs growth in Life Sciences arena APSCo
24-Nov-2022 Besins Healthcare launches Dimetrum® (dienogest) 2mg for the treatment of endometriosis in the UK Besins Healthcare UK
24-Nov-2022 Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease Allero Therapeutics
24-Nov-2022 SynBiotic SE attracts Canopy Growth founder Bruce Linton as Chairman of newly created Advisory Board SynBiotic SE
24-Nov-2022 Asklepios Kliniken: Sound business performance in first nine months of 2022 Asklepios Kliniken
24-Nov-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
24-Nov-2022 Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects Tiziana Life Sciences Ltd.
24-Nov-2022 Körber expands local software offering for the life sciences industry in Italy Körber
24-Nov-2022 MPH Health Care AG: Q3 result 2022 MPH Health Care AG
24-Nov-2022 Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022 Medios AG
23-Nov-2022 AC Immune to Present Progress of Alzheimer’s Disease Programs targeting Abeta and Tau at the 15th CTAD Conference AC Immune
23-Nov-2022 Is Pharma Marketing built on Straw, Sticks or Bricks? PM Society
23-Nov-2022 Alliance Pharma Update on Q4 trading Alliance Pharma
23-Nov-2022 Alliance Pharma Management Update Alliance Pharma plc
23-Nov-2022 HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer HpVac SA
23-Nov-2022 Defence Therapeutics Inc.: DEFENCE’S SUCCESSFULL STUDY ON THE ACCUVAC-PT007 VACCINE TARGETING CERVICAL CANCER Defence Therapeutics Inc.
23-Nov-2022 Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH Kuros Biosciences AG